Perigord releases most powerful GLAMS yet – GLAMS 5.0
Perigord announces the release of GLAMS 5.0, the latest update to its industry-leading AMS platform. Developed to the specific needs
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded
AavantiBio and Catalent Announce Partnership to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases
AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Catalent, the leading
CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply
CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted
Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
Scivita Medical Technology Co., Ltd. (“Scivita Medical”) announced that it has raised nearly RMB0.4 Billion in Series A funding round,